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Professor Rothenberg’s Scholarship  
takes a Dramatic Turn
Dr. Hardy: So I need to share the seriousness of the finding [of a genetic 
predisposition to Long QT syndrome that may cause arrhythmia and 
sudden cardiac arrest] with Sam and tell her we very strongly recommend 
that competitive athletics be forsaken.
Mom: Oh no, you can’t tell her anything is wrong.  Remember you just 
said doctors don’t tell kids Sam’s age.  And anyway, remember you told 
me these tests aren’t certain!
Dr. Hardy: You are correct that for kids we typically do not report most 
disease susceptibility that may affect them later in life.  This however has 
immediate implications.  There is the potential for sudden death without 
treatment and an excellent outcome with treatment – including taking 
a medication to protect the heart.  We’ve already confirmed this result 
in a CLIA lab.  Because of the severe ramifications for some kids – and 
we don’t know who – I must inform her so she’ll give up competitive 
swimming.
Mom:  No . . . that would devastate her . . . let’s wait till high school 
then I can just say I have to go to work earlier so can’t’ take her to 6 am 
swim practice.  
Dr. Hardy: She should be closely followed by a cardiologist, who may 
also consider beta blockers or an implantable defibrillator.  We really 
need to bring Sam into this discussion now . . .
This difficult conversation is from the play “It’s So Complicated” co-
authored by Law & Health Care Program Professor Karen Rothenberg 
and Columbia University Medical Center faculty member Dr. Lynn Bush.  
The play is included in their new book The Drama of DNA: Narrative 
Genomics.  The scene depicts a situation in which whole genome 
sequencing (a genetic laboratory process that determines the complete 
DNA sequence of a person's genome at a single time) revealed genetic 
information that was unrelated to the reason the family sought genetic 
testing in the first place.  Given the rapid growth in our understanding of 
the human genome and the decreased costs of whole genome sequencing, 
patients and researchers will have to have these difficult conversations 
about “incidental findings” and other complex concerns much more 
frequently.  
Spring 2014
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Prof. Rothenberg
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Finding ways to confront and address these concerns has always been 
at the heart of Rothenberg’s scholarship, but using drama to do so has 
been Rothenberg’s consuming passion for the last five years. Rothenberg 
and Bush's new book brings together their collaborative work on the 
use of dramatic narrative to understand and facilitate conversations 
about genomics.  The book uses excerpts from Rothenberg and 
Bush’s original plays as well as plays by other authors to examine the 
implications of genomic technologies in today’s society and to foster a 
greater understanding of how genomic information should be evaluated, 
processed, and shared.  In his foreword to the book, Dr. Eric Green, 
Director of the National Human Genome 
Research Institute (NHGRI), comments 
that this “novel approach successfully 
generates a constructive dialogue about 
the ethical, psychological, and societal 
challenges that develop with the infusion 
of genomics into real-world situations.”  
The book, which links readers to online 
versions of the plays, promises to be 
an invaluable resource to health care 
providers and researchers and ultimately 
to patients.  As Dr. Green notes in his 
introduction, a great deal of interest has 
already been expressed by members of 
the scientific community in early versions 
of the plays in the book.    
The Drama of DNA is the culmination 
of Rothenberg’s long-time work studying 
the social implications of genetic 
research and her personal love of theatre.  After serving as the Dean of 
UM Carey Law for 10 years, Rothenberg spent academic year 2009-
2010 on sabbatical to focus on theatre as a structured and stimulating 
avenue to engage students and the public in identifying and discussing 
complex health and science policy issues.  She spent her sabbatical year 
as a Visiting Professor at the Berman Institute for Bioethics at the Johns 
Hopkins University, Scholar-in-Residence at Columbia Law School, and 
Senior Sabbatical Fellow at Colombia University Law School’s Center 
for the Study of Law and Culture.  She also began her collaboration with 
Dr. Lynn Bush, Ph.D., M.S., M.A., who shares Rothenberg’s interest in 
exploring the use of plays and musicals as a way to encourage dialogue 
on complex health and science issues and to identify issues of concern 
that should be taken into consideration by health policy makers.  
In spring 2010, Professor Rothenberg was asked to give the Robert L. 
Levine Lecture at Fordham University School of Law.  The talk, which 
formed the basis for the article “From Eugenics to the ‘New’ Genetics: 
The Play's The Thing,” published in the Fordham Law Review, focused 
Professor Karen Rothenberg's 
new book: The Drama of DNA
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on the way theatre engages viewers in a dialogue about 
the society they live in.  The talk and the subsequent 
article examined the relationship between public 
opinion and social policy to explore connections and 
parallels between the eugenics studies of yesteryear 
and modern genetic science, especially with respect 
to the role of women and their accountability to future 
generations through their reproductive choices.  This 
article provided a historic perspective on how science 
has been portrayed in theatre which led Rothenberg 
to consider whether, and how, plays can be used as a 
vehicle to engage stakeholders in the present.
Returning to the law school in 2010-11, Rothenberg 
continued her focus on how best to bring to life the 
ethical and societal issues raised by emerging genomic 
technologies. She created an innovative course together 
with National Institutes of Health (NIH) bioethicist 
Ben Berkman called the “Health and Science Policy 
Workshop: The Regulation of Genomic Research” in 
which Maryland law students studied the cutting edge 
bioethical issues raised by whole genome sequencing 
and presented their findings to a group of NIH 
researchers, including NHGRI Director Eric Green (see 
Law and Health Care Newsletter, Fall 2011).
In the meantime, Professors Rothenberg and Bush 
continued their long distance collaboration and co-
authored two short plays to help convey the complexity 
of ethical issues raised by genomic research that 
were presented at the 2011 Ethical, Legal, and Social 
Implications (ELSI) Congress sponsored by NHGRI. 
The first play, “It's Not That Simple,” focused on 
whole genome sequencing and the informed consent 
process in the context of personal and professional 
relationships. The second play, “It's So Complicated!” 
highlighted dilemmas involved with returning research results and incidental findings to study participants in 
the course of whole genome sequencing.  The first play was published in the February 2012 issue of Genetics 
in Medicine along with a corresponding article on the theory and process of developing the play, followed 
by the second play and accompanying commentary in the March 2012 issue of the same journal.  These two 
plays and several others they have co-authored have been welcomed by professionals who work in the area of 
genomics, including bioethicists, doctors, researchers, and NIH staff.  The plays are designed to be acted out 
by these professionals and students who take roles in the play that are different from what they do in “real life.”  
Rothenberg believes this is critical in order for people to “hear the other voice” on a particular issue.  The plays 
have been performed by interdisciplinary groups of professionals in Australia, the Netherlands, and London 
and at the annual meetings of the American Society of Human Genetics, the American Society for Bioethics 
and Humanities, and several institutes within NIH.  Recently Rothenberg engaged the staff of the Presidential 
Commission for the Study of Bioethical Issues in reading one of the plays aloud. 
Following Rothenberg’s return to the law school, she was asked to join NHGRI to study innovative ways 
Cont. on page 4
Selected Works on Genetics and Genomics 
 by Professor Rothenberg
• The Drama of DNA: Narrative Genomics, (with 
L.W. Bush) Oxford Univ. Press (2014)
• “Finding Fault? Exploring Legal Duties to 
Return Incidental Findings in Genomics 
Research,” (with E.R. Pike and B.E. Berkman), 
102 Georgetown L.J. 795 (2014)
• “Setting the Stage: Enhancing Understanding 
of Bioethical Challenges with Theatre,” 11 Ind. 
Health L. Rev. 1 (2014)
• “Manipulating Fate: Medical Innovations, 
Ethical Implications, Theatrical Illuminations,” 
13 Houston Journal of Health Law & Policy 1 
(2012)
• “Teaching Students to be Policymakers: The 
Health and Science Policy Workshop on 
Genomic Research,” in “Teaching Health Law,” 
J Law Med Ethics, (with B. Berkman) 2012 
Spring;40(1):147-53
• “Dialogues, dilemmas, and disclosures: genomic 
research and incidental findings,”(with L.W. 
Bush) Genet Med, 14(3):293-5 (2012)
• “Genes and plays: bringing ELSI issues to life.” 
(with L.W. Bush) Genet Med, 14(2):274-7 
(2012)
• “From Eugenics to the ‘New Genetics’: The 
Play’s the Thing,” 79 Fordham Law Review 407 
(2010)
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to engage professionals and the public in the very 
complex – and potentially unsettling – work of 
genomic research. This is not the first time Professor 
Rothenberg has worked with NIH. During sabbaticals 
and leaves from the UM Carey School of Law, she 
worked in the NIH Office of Research on Women's 
Health and the National Institute for Child Health 
and Human Development.  She now serves as Senior 
Advisor on Genomics and Society to the Director 
of NHGRI, and as a visiting scholar at the NIH 
Department of Bioethics on leave from the University 
of Maryland Francis King Carey School of Law.  Her 
work at NIH is a logical next step for Rothenberg 
who has spent the last two decades focused on the ethical, legal and social implications of genetic testing and 
research, including legislative approaches to genetic information in the health insurance and employment 
context, the impact of genetic research on racial and ethnic populations and women's health care, and the use of 
genetic information in the courtroom.  At NIH, one of her goals was to find a common language with which the 
many stakeholders in the field of genomics could communicate.
By 2012, Professor Rothenberg’s research and collaboration with Dr. Bush led to a joint article that examined 
46 plays — spanning three centuries — to enhance understanding of the ethical and social impact of medical 
technology on society.  The article, “Manipulating Fate: Medical Innovations, Ethical Implications, Theatrical 
Illuminations,” which appeared in the Houston Journal of Health Law & Policy, was divided into six "acts" that 
highlighted different ways that theatre has dealt with science – from expressing our fear of science, to justifying 
bad science, to tackling complex bioethical issues raised by new science.  The plays discussed in the final 
section of the article, "Genomes & Unknowns," spotlight how the new genomics revolution intensifies human 
hopes and expectations for medical innovations, treatments and cures. The plays featured in the article explore 
such ethical dilemmas as:
• Who should or can control the fate of future generations through the use of emerging prenatal    
 technology?   
• Should there be limits on how cutting edge genomic technologies are used to change the fate of others?
• How should we decide who gets access to emerging medical technologies?
 In February 2013, Professor Rothenberg was recognized for her outstanding contributions to the health 
law field by Indiana University School of Law. She was asked to give the McDonald Merrill Ketcham Award 
Lecture and facilitate a panel discussion called “Setting the Stage: Enhancing Understanding of Bioethical 
Challenges with Theatre,” which led to a 2014 article in the Indiana Health Law Review by the same title.  This 
discussion, that included faculty members from the Indiana University School of Medicine, the artistic director 
of the Indiana Repertory Theater, and a medical historian, was designed to show how theatre can be used to 
identify and resolve our ethical challenges in health care.  
Recently, Rothenberg had another chance to discuss her work in a setting outside the walls of NIH – at the 
Smithsonian.  On April 10, Rothenberg moderated a discussion with several contemporary playwrights who 
have used theatre to examine the ethical, legal, and social issues that genomics have introduced into our lives, 
as well as to stimulate conversations about biomedical research.  Playwrights Dorothy Fortenberry (The Good 
Egg), Lisa Loomer (Distracted), Cassandra Medley (Relativity), and Anna Ziegler (Photograph 51) discussed 
Prof. Rothenberg
Cont. from p. 3
Cont. on page 11
Panel Discussion with Playwrights at Smithsonian
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Network for Public Health Law Eastern Region 
directed by Professor Kathleen Hoke 
Takes on Problem Gambling
The Network for Public Health Law’s Eastern Region, housed 
at the UM Carey School of Law, is working with the University 
of Maryland School of Medicine’s Center for Excellence in 
Problem Gambling to reduce the negative public health issues 
associated with gambling. The Network’s Eastern Region, 
which is directed by UM Carey Law Professor Kathleen Hoke, 
is providing the Center with legal guidance and policy research, 
with a particular emphasis on prevention of underage and 
compulsive gambling. The Center is funded by the Maryland 
Department of Health and Mental Hygiene (DHMH) and 
is supporting the salary of Special Projects Fellow Athena    
Cymrot ’11. 
Underage gambling is a growing concern in the United States 
and the legalization of casinos offering slot machines and table 
games in Maryland has brought the issue to the forefront. To 
help the Center respond to legislative proposals on the subject, 
the Network drafted a policy brief on underage gambling and the 
public health issues it raises, as well as an overview of gambling and gaming laws across the United States. The 
policy brief outlined the negative physical, mental, and social consequences of gambling, especially in young 
people. The report noted that the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-V) lists "Gambling Disorder" as an addictive disorder that disrupts personal, family, and vocational 
pursuits.1 Additionally, problem and pathological gamblers experience other psychological issues, such as 
mood disorders and other addictions, as well as interpersonal issues like lying, stealing, and poor work or 
school performance.2 Gambling is also linked with an unusually high risk of suicide.3  The report noted that the 
prevalence of gambling problems is higher in adolescents than in adults.4 In fact, the prevalence of gambling 
problems in youth may be up to three times the prevalence in adults5 with an estimated 4 to 8% of adolescents 
suffering a serious gambling problem and another 10 to 15% of youth at-risk of developing a gambling 
problem.6 
The field of youth gambling prevention is relatively new and very little has been done in terms of studying 
and preventing the problem. As a result, not much is known about the efficacy of programs and policies to 
prevent problem gambling in youth.7 This gap in scholarship is where the Center for Excellence in Problem 
1 tHe DiagNostiC aND statistiCaL MaNuaL of MeNtaL DisorDers, § 312.31(Am. Psychiatric Ass’n 5th ed.) (2013). 
2 J. Nick Badgerow, Apocalypse at Law: The Four Horsemen of the Modern Bar - Drugs, Alcohol, Gambling, and Depression, 77-FEB J. KAN. B.A. 
19, 22; Judy Herriff, Gambling: The Hidden Addiction, 88-MAY MICH. B.J. 54, 54. 
3  Sanju George & Vijaya Murali, Pathological Gambling: An Overview of Assessment and Treatment, 11 ADVANCES IN PSYCHIATRIC TREAT-
MENT 450, 451 (2005).
4 Carmen Messerlian et al., Youth Gambling Problems: A Public Health Perspective, 20 HEALTH PROMOTION INT’L 69, 70 (2005). 
5 Jeffrey Derevensky et al., Adolescent Problem Gambling: Legislative and Policy Decisions, 8 GAMING L. R. 107, 108 (2004). Jeffrey Derevensky 
et al. 
6 Judy Herriff, Gambling: The Hidden Addiction, 88-MAY MICH. B.J. 54, 54. 
7  Prevention Efforts Toward Reducing Gambling Problems; Jeffrey Derevensky, Rina Gupta, Laurie Dickson, Anne-Elyse Deguire (213); Jeffrey 
Derevensky & Rina Gupta, Adolescents with Gambling Problems: A Synopsis of Our Current Knowledge, ELEC. J. OF GAMBLING ISSUES, 9 
(2004), available at http://youthgambling.mcgill.ca/en/PDF/Publications/2004/ejgi-issue10.pdf.
Cont. on page 11
Professor Kathleen Hoke
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Rome Lecture and Roundtable Organized 
By Professor Amanda Pustilnik Focus on 
Neuroimaging and the Law
On April 24 and 25, the Law & Health Care Program (L&HCP) 
held two events focusing on neuroimaging and the law. Both were 
the result of efforts by L&HCP Professor Amanda Pustilnik, a 
national expert on legal issues presented by neuroscientific work on 
memory and pain. The first event was the L&HCP’s annual Rome 
Lecture which was given this year by Stanford Law Professor 
Hank Greely on the topic of “Neuroimaging, Mindreading, and 
the Courts.” The annual Rome Lecture is presented each year by 
a scholar renowned in health law and policy.  Professor Greely is 
the Director of the Center for Law and the Biosciences at Stanford 
School of Law and Director of the Stanford Interdisciplinary Group 
on Neuroscience and Society. Professor Greely’s Rome Lecture is 
available at https://www.youtube.com/watch?v=s7PwDahionk.
Professor Greely’s talk was a kick off to the interdisciplinary 
roundtable that took place the following day on the topic of 
“Imaging Brains, Changing Minds: Chronic Pain Neuroimaging 
and the Law.” The roundtable was designed to create a dialogue 
between the fields of law and neuroscience and to make legal 
actors aware of recent breakthrough work in neuroimaging that 
has led to a paradigm shift in understanding chronic pain. This 
new science has the potential to change legal doctrines and shift 
legal and cultural norms about chronic pain diseases and their sufferers. Professor Pustilnik organized and 
moderated the roundtable in collaboration with Dr. David Seminowicz from the Department of Neural and Pain 
Sciences at the University of Maryland School of Dentistry, and with the support of the American Association 
for the Advancement of Science’s Human Rights and Law program. Prominent legal academics, scientists and 
judges attended the roundtable which will result in, among other outcomes, a symposium issue of the L&HCP’s 
Journal of Health Care Law & Policy next year.
The roundtable was divided into four panel sessions that focused on different 
topics relating to the overall theme of the roundtable. Speakers in the first panel, 
including Hank Greeley, Dr. Karen Davis who heads the Division of Brain, 
Imaging and Behaviour-Systems Neuroscience at Toronto Western Hospital, 
and Judge Andre Davis of the U.S. Court of Appeals for the Fourth Circuit, 
introduced legal actors to the neuroimaging-based breakthroughs in chronic pain 
science and described the primary legal areas where chronic pain is at issue. The 
panel also discussed the differences between the models of chronic pain in pain 
science versus in law and how chronic pain neuroimaging could affect three legal 
domains: legal doctrine, judicial interpretation, and courtroom practice. 
The second panel focused on the ways in which disability law struggles with 
claims of “excess pain” – where the claimant alleges more pain than would be 
expected for the injury or disease. Roundtable participants and the panelists, who 
included Professor Adam Kolber of Brooklyn Law School, Judge Morris Hoffman 
of the Denver District Court, Joel D. Greenspan who chairs of the Department of 
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Professor Michael Pardo of University of Alabama, 
discussed how neuroscience can help us make sense 
of individual variability in pain and how policymakers 
and legal actors can exercise judgment about whether a 
claimant is credible. 
The third panel focused on links between emotion 
and chronic pain and the legal consequences of 
considering chronic pain as “physical” or “emotional”. 
Panelists Professor Robert Dinerstein of American 
University, Dr. Jennifer A. Haythornthwaite of the 
Department of Psychiatry and Behavioral Sciences 
at Johns Hopkins University School of Medicine, 
Professor Jennifer Chandler of University of Ottawa 
Law School, and Dr. Tor D. Wager of the Department 
of Psychology and Neuroscience at University 
of Colorado, discussed the current scientific and clinical importance of distinctions between organic and 
psychogenic pain and when legal doctrines do – and when they should – distinguish between these pain 
etiologies. 
The final panel addressed the use of scientific evidence to make a legal case or reach a legal decision. 
The panel members, Judge Nancy Gertner (ret.) of the U.S. District Court for the District of Massachusetts, 
Professor Stacey Tovino of the University of Nevada’s Boyd School of Law, and Dr. Martha J. Farah who 
directs the Center for Neuroscience and Society at the University of Pennsylvania, explored why attorneys and 
adjudicators may want to use neuroimaging as evidence of chronic pain in court but why neuroimaging can be 
reliable in aggregate to educate legal actors, i.e. judges, juries and policy makers, about brain conditions but not 
(or not currently) as reliable proof of individual conditions. 
Professor Amanda Pustilnik is an Associate Professor of Law at the University of Maryland School of Law, 
where she teaches Criminal Law, Evidence, and Law & Neuroscience. Prior to joining the University of 
Maryland, she was a Climenko fellow and lecturer on law at Harvard Law School. Before entering the legal 
academy, she practiced litigation with Covington & Burling and with Sullivan & Cromwell, where she focused 
on white collar criminal matters. Professor Pustilnik also clerked for the Hon. Jose A. Cabranes on the United 
States Court of Appeals for the Second Circuit. She graduated Yale Law School and Harvard College, and 
has been a visiting scholar at the University of Cambridge, Emmanuel College, in the History and Philosophy 
of Science department. Professor Pustilnik has also worked at McKinsey & Company as a management 
consultant and is a member of the board of directors of the John Harvard Scholarships.
More information about the roundtable and complete bios of the participants are available at the roundtable 
website: https://www.law.umaryland.edu/faculty/conferences/detail.html?conf=166.
The roundtable was generously supported by a gift from Alan & Nancy Eason, as well as proceeds from the 
Reuben Shiling Mental Health Law Fund, the Leonard C. Homer/Ober|Kaler Law and Health Care Fund, and 
the Dr. Richard H. Heller Fund.
Professor Pustilnik and Participants 
at Neuroscience Roundtable
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Law & Health Care Program Honors Adjunct 
Professors Sanford Teplitzky  and Kevin McAnaney
Next year will be the first time in over a decade that the Law & Health Care 
Program (L&HCP)’s Fraud and Abuse Seminar will not be taught by the 
adjunct teaching duo of Sanford (Sandy) Teplitzky and Kevin McAnaney.  The 
two beloved professors have taught the seminar nine times, starting in 2002.  
In addition to bringing the complex issues of fraud and abuse to life in the 
classroom, Teplitzky and McAnaney have mentored students through health 
law competitions, externships and the process of entering the job market.  
They are well known for their mastery of the subject matter and their great 
humor in the classroom.  Although the seminar will be taught by well-qualified 
replacements who are certain to gain a following of their own, L&HCP alums 
who have worked with Teplitzky and McAnaney reacted with sadness at the 
news of their (well-deserved) break from teaching:
• “I am very grateful that I had the privilege to be a student in Professors 
McAnaney and Teplitzky's class.  Their energy and passion for teaching 
made every class a pleasure to attend, and the subject of fraud and abuse 
that much more interesting to learn.  I hope that they will teach again so 
that other students may have the opportunity to learn from their insights 
and experiences.” – Melanie Dang ’14
• “Learning the fundamentals of healthcare fraud and abuse from two 
professors who helped write, develop, and litigate many of the statutory 
and regulatory provisions health lawyers practice with every day was 
truly priceless. I continue to use many of the materials, notes, and 
outlines I prepared in Professors Teplitzky and McAnaney’s class, and 
the paper I wrote during my semester with them was published by ABA’s 
Health Lawyer as a runner up in their 2012 competition.” Abe Gitterman 
’13, Associate, Arnold & Porter
• “Professors McAnaney and Teplitzky taught our class the fundamentals 
we needed to start our careers as health lawyers.  They taught beyond 
the law, using their extensive experiences to give us keen insights few 
other health law students received. Potential employers trusted that I 
was well trained because they knew I had been taught by these esteemed 
practitioners.”- Hannah Levinson ’13, Associate, Broad & Cassel
Teplitzky is Principal and Co-Chair of the Health Law Practice Group at the 
Baltimore law firm of Ober|Kaler.  His clients are primarily large health care companies and delivery networks 
for whom he provides advice on a variety of fraud and abuse issues.  He is one of the most prominent health 
lawyers in the U.S. and is a former president of the American Health Lawyers Association which awarded him 
the prestigious David J. Greenburg Award in 2008.  Prior to joining Ober|Kaler, Teplitzky served as an attorney 
for the Office of the General Counsel of the Department of Health, Education and Welfare, where he provided 
legal advice to the Health Care Financing Administration and was the primary author of policies and regulations 
relating to the Medicare and Medicaid Anti-Fraud and Abuse Amendments of 1977.  About his departure from 
the law school, Teplitzky said, “It has been a privilege and an honor to be a part of the faculty at the University 
of Maryland School of Law for the last 12 years.  There were many people who served as mentors for me (many 
years ago) and I am thrilled that I played even a small role in the education of the next generation of 
health lawyers.”  
Sanford Teplitzky
Kevin McAnaney
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McAnaney is a nationally recognized expert on health care fraud and abuse. His solo practice concentrates 
on fraud and abuse matters, including compliance reviews, transactional work, and civil and administrative 
litigation.  He served as the Chief of the Industry Guidance Branch of the Office of Counsel to the Inspector 
General from its creation in 1997 until May, 2003 where he worked closely with the Department of Justice to 
develop cases involving the anti-kickback and Stark statutes, including the use of such claims as predicates 
for False Claims Act litigation.  Prior to joining the federal government, McAnaney was a partner in the 
Washington, D.C. law office of Dewey Ballantine where he practiced health care, food and drug, and 
environmental law.  While there he mentored Diane Hoffmann who went on to become Professor of Law and 
Director of the L&HCP at Carey Law. About teaching his last class, McAnaney said “[w]hile I will not miss 
the commute from Washington, I will miss the students.  They are uniformly bright, knowledgeable, and well-
spoken. Given all the doom and gloom being spread about the current practice of law, I hope Sandy and I 
conveyed to them how much sheer fun it can be to practice in a field you love.”
Professor Hoffmann, who brought McAnaney and Teplitzky together in 2001, said that “Maryland has been 
extremely fortunate to have this dynamic duo teach our fraud and abuse course and to have them as part of our 
health law program faculty.  Every year the course had a waiting list and Kevin and Sandy were always very 
generous in their willingness to accept students into the class from off the list.  They have enriched our students 
and our Program and they will be sorely missed.”
Health Law Regulatory & Compliance Competition
On February 8, 2014, the Law & Health Care Program (L&HCP) held the 3rd Annual Health Law Regulatory 
and Compliance Competition. The Competition 
is designed to put students in the shoes of health 
law attorneys and regulators who handle complex 
regulatory and compliance questions.  This year, 
twelve teams from around the country participated in 
the competition including teams from the law schools 
at Loyola University Chicago, Saint Louis University, 
Southern Illinois University, Catholic University, 
Drexel University, University of Texas, American 
University, University of Pennsylvania, Georgia State, 
Seton Hall, and Cardozo (and a UM Carey Law team).  
This year, the team from Seton Hall gained first place 
honors.   
During the competition, teams of three students 
analyzed a fact pattern using federal health regulations, 
rules, and agency documents, and presented a legal 
and policy solution and/or recommendations to a panel 
of regulatory and compliance attorneys.  This year’s competition, which was organized by L&HCP Professor 
Frank Pasquale, Abe Gitterman (UM Carey ’13 now an associate at Arnold & Porter) and Sean Gugerty (2L), 
focused on clinical research in the long term care setting. The competition, which was sponsored by the law 
firm of Ober|Kaler, included judges from some of the country’s most prominent health law firms including 
Arnold & Porter, Ober|Kaler, Epstein Becker & Green, and Hyman, Phelps & McNamera, as well as the 
Department of Health and Human Services Office of the Inspector General, FDA, CMS, and private industry.  
More details about the competition and judges is available at this link: https://www.law.umaryland.edu/
regulatorycompetition. 
Professor Frank Pasquale (right) talks to students 
at reception after competition
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This month, the National Institutes of Health (NIH) 
is holding a symposium to commemorate 10 combined 
years of research funded by the NIH Roadmap and the 
NIH Common Fund, two grant programs that were cre-
ated to encourage innovation in biomedical research.  
L&HCP Director Diane Hoffmann was funded by the 
Common Fund’s Human Microbiome Project in 2010, 
along with an interdisciplinary group of researchers 
at the University of Maryland Baltimore (UMB), to 
examine and make recommendations regarding the 
regulation of probiotics.  As part of the 10 year com-
memoration of the NIH Roadmap/Common Funds, 
the NIH Office of Strategic Coordination organized a 
video competition to encourage creative descriptions 
of Roadmap/Common Fund programs to be shared 
with the general public.  Hoffmann and her UMB co-
investigators submitted a humorous video about their 
probiotics project based on the television program Law 
& Order: Special Victims Unit.  The video depicted a 
day in the life of the “Special Claims Unit” that was 
investigating an egregious false claim on a package of 
a fictitious probiotics called “Probiotic Cure-All.”  In 
addition to law students, Diana-Lynne Hsu and Bill 
Rader, Hoffmann acted in the video with co-investi-
gators Dr. Frank Palumbo (School of Pharmacy), Dr. 
Jacques Ravel (Institute of Genome Sciences, School 
of Medicine), and Virginia Rowthorn (School of Law).  
Hoffmann’s video depicts a young man buying a 
probiotic formula because of the exaggerated claims 
on the package, having an adverse reaction, and sub-
sequently reporting it to a physician who calls in the 
Special Claims Unit to investigate the false claims.  
The action then shifts to a court room where the manu-
facturer of Probiotic Cure-All is being raked over the 
coals by an indignant judge who decries the lack of substantiation behind the product’s claims.  The video ap-
pears at the following YouTube link: https://www.youtube.com/watch?v=Ani0bEORweY.
Professor Hoffmann’s NIH-Funded Probiotics 
Project Takes a Dramatic Turn As Well
Opening Screen of NIH Video Contest Submission 
by L&HCP
Bill Rader ('14), Adjunct Professor Frank Palumbo, 
and L&HCP Director Diane Hoffmann
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why and how they used complex topics rooted in genetics —including issues of identity, the power of genetic 
information, and the impact of health decisions on family dynamics—in their work, all discussed in the article 
"Manipulating Fate" and the book, The Drama of DNA.  The program was designed to complement the National 
Museum of Natural History exhibition “Genome: Unlocking Life's Code,” which is co-sponsored by NHGRI 
and for which Rothenberg was asked to conduct public outreach.  The exhibit opened on June 14, 2013 and will 
close on September 1, 2014 to travel throughout North America.  On the morning of the event, Rothenberg also 
organized an NIH workshop for playwrights and scientists to talk about the process and challenges of writing 
about complex scientific issues and the opportunities for enhancing collaborations between the artistic and 
scientific communities in the future.   
What’s next for Rothenberg?  In addition to her work on theatre and genomics, she has continued to study the 
legal and ethical ramifications of genetic testing and serve as a resource to policy makers who make decisions 
about how best to protect patients and foster responsible and creative science.  She recently co-authored a paper 
“Finding Fault? Exploring Legal Duties to Return Incidental Findings in Genomics Research,” which goes back 
to the scenario that started this article – how to deal with the issue of incidental findings that come up when 
the whole genome of an individual is sequenced.  As science continues its inevitable march forward, Professor 
Rothenberg will have ample opportunity to apply the lessons she has learned through legal study and theatre to 
ensure that we meet new science together with a shared approach to what is best for all members of society.
Prof. Rothenberg
Cont. from p. 4
Problem Gambling
Cont. from p. 5
Gambling comes in. Most recently the Network provided legal and policy guidance to the Center in its support 
of Maryland House Bill 275 and Senate Bill 481, which would prohibit individuals under the age of 21 from 
entering a casino or participating in any casino games, making a violation a civil offense punishable by a fine. 
The General Assembly passed the legislation during the 2014 session and Maryland Governor Martin O’Malley 
recently signed the bill that will go into effect on October 1, 2014. The Network will produce an informational 
brochure for Maryland’s judiciary and local law enforcement officials to explain the new law and its purpose 
and to let those officials know about the resources the Center provides for those experiencing gambling 
problems. 
The Network and Center are now beginning work on the topic of Internet gambling, specifically looking at 
whether and how Internet gambling could be regulated to prevent underage and compulsive gambling. Other 
projects will be developed in collaboration with the Alcohol and Drug Administration at DHMH and the 
Maryland Council on Problem Gambling.
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Comments and letters should be 
forwarded to the above address.
The Law & Health Care Program mourns the loss of Adjunct Professor Robert T. M. Phillips, who died 
April 18th after a long battle with myelofibrosis. He was 62. 
Professor Phillips began teaching at UM Carey Law in 1996. He was also an adjunct associate professor 
of psychiatry at the University of Maryland School of Medicine, and a lecturer and former assistant clinical 
professor of psychiatry at Yale University School of Medicine. This semester, he was co-teaching the Mental 
Disability and Criminal Law Seminar at the School of Law.
Professor Phillips was the medical director for Forensic Consultation Associates, Inc., which specializes 
in psychiatric consultations in civil and criminal litigation, and counted the U.S. Department of Justice and 
the U.S. Secret Service among his regular clients. He was also frequently enlisted by Stephen Bright of the 
Southern Center for Human Rights to evaluate the mental status of death row inmates. 
Phillips was a distinguished fellow of the American Psychiatric Association, and served as its deputy 
medical director from 1993 to 1998. Lawrence Fitch, with whom Phillips co-taught for 19 years, says that 
throughout the long and prosperous career that followed that difficult moment, “his moral compass never 
deviated” and “his commitment to social justice endured.”
